ad image

EQT

1 / 1
EQT
Financing

EQT Life Sciences leads €54 Million Series A Financing of ATB Therapeutics

EQT

PR-11-24-NI-116Nov 20, 2024
Aldevron
M&A

EQT to Acquire Majority Interest in Aldevron – the Leading Global Supplier of Plasmid DNA Used in Cell and Gene Therapies

Aldevron

PR-M07-19-NI-081Jul 31, 2019
1 / 1